114PA PHASE 1B STUDY OF ANTI-DLL4 (DELTA-LIKE LIGAND 4) ANTIBODY DEMCIZUMAB (DEM) WITH PEMETREXED (PEM) AND CARBOPLATIN (CARBO) IN PATIENTS WITH 1ST-LINE NON-SQUAMOUS NSCLC


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles